Products

Lifebit Federated Research & Discovery
Lifebit
Drug Discovery & Research
Lifebit Federated Research & Discovery is a federated data platform with AI-powered harmonization for secure, compliant real-world data analytics, enabling research without moving sensitive data.

See all 1 product →

About Lifebit

Lifebit is a healthcare AI company that specializes in advanced genomics and health data solutions, offering innovative software designed to enhance the access and analysis of biomedical data across multiple sectors. The company’s core mission is to democratize access to global biomedical data, allowing researchers, organizations, and public bodies to access and analyze vital information in the pursuit of life-changing precision medicine and drug discovery. Lifebit’s platform brings analysis directly to where the data resides, accelerating drug discovery, personalized medicine, and disease research.

For physicians, Lifebit provides solutions that aim to streamline end-to-end clinical and Next-Generation Sequencing (NGS) analysis with AI and advanced analytics. Their offerings include a Trusted Clinical Environment (TCE) that enables secure, compliant environments for transforming data into validated clinical outcomes. The TCE utilizes AI-driven analytics for deep clinical and molecular data interpretation, scrutinizing patient-specific genomic data to detect significant genetic variants that could inform therapeutic strategies. Physicians can also benefit from variant filtering and therapy recommendations by accessing renowned databases, as well as pharmacogenomic reporting to guide treatment and dosage. Lifebit’s Clinical Genomics Portal v2 further enhances these capabilities by integrating AI and advanced software with genomic and health data to improve data management, diagnostics, and personalized treatments, including seamless integration with major Electronic Health Record (EHR) systems like EPIC and Cerner.

Focus Areas

genomics bioinformatics precision medicine health data solutions AI-powered data analytics federated learning drug discovery clinical trials population genomics real-world data (RWD)

Business Intelligence

Key InvestorsTiger Global Management, Idinvest Partners, Pentech Ventures, Beacon Capital, Connect Ventures, Eurazeo, AngelList, BEENEXT, DST Global, Fundamentum, Matrix Partners India, Kunal Shah, Jim Rowley, Mark Mastrov, Philipp Moehring, Maria Dramalioti-Taylor
PartnershipsGenomics England, Boehringer Ingelheim, Hong Kong Genome Project, NIH, 23andMe, Singapore Ministry of Health, Flatiron Health, CanPath, Psifas, Synapxe, Cancer Research Horizons, Omica
TechnologyLifebit Federated Platform (Lifebit CloudOS), federated lakehouse architecture, cloud-native, AI-Automated Airlock, Trusted Research Environment (TRE), Trusted Data Lakehouse (TDL), Trusted Data Marketplace (TDM), Nextflow, Kubernetes, Docker, Spark, JupyterLab, RStudio

What Physicians Need to Know

Genomics & Bioinformatics
Lifebit specializes in secure and compliant access to genomic and biomedical data, offering a unified computational environment for managing, processing, analyzing, and sharing complex biological datasets. They automate data ingestion, quality control, and provide workflow orchestration for reproducible and scalable bioinformatics pipelines, supporting diverse formats like FASTQ, BAM/CRAM, and VCF.
Precision Medicine & Health Data Solutions
Lifebit's Federated Platform is purpose-built for precision medicine, harnessing multi-modal and multi-omic data to generate transformative insights. They enable secure and safe access to genomic and biomedical data through Trusted Research Environments (TREs), also known as 'Data Safe Havens,' which are highly secure and controlled computing environments. Their solutions support the transformation of health data management, including standardization to OMOP, FHIR, and GA4GH standards.
AI-Powered Data Analytics & Federated Learning
Lifebit is a global leader in federated, secure, and AI-powered data intelligence platforms. They enable AI-driven analytics by bringing computation to the data, allowing institutions to train powerful AI models on distributed datasets without sharing sensitive patient information. Their AI-Powered Federated Data Hubs allow natural language queries to be converted into federated SQL queries, making complex data exploration accessible.
Drug Discovery & Clinical Trials
Lifebit accelerates drug discovery by enabling secure, real-time AI-powered drug discovery through federated data platforms. Their solutions support target identification and validation by integrating population genomics, clinical data, and biomedical knowledge. For clinical trials, Lifebit provides solutions to unify data, accelerate timelines, and enhance patient engagement, offering secure platforms to connect, manage, and analyze clinical trial data.
Population Genomics & Real-World Data (RWD)
Lifebit's Federated Platform enables secure data harmonization and federated analysis across national biobanks, health systems, and research centers for population genomics, without moving sensitive data. They provide secure access to real-world data (RWD) for oncology research and other therapeutic areas, integrating phenotypic, genomic, pathology, imaging, and treatment outcome data to understand disease biology and personalize treatment plans.
Physician Tip

For physicians, Lifebit's platform offers several key advantages. The **Trusted Clinical Environment** aims to turn data into clinical actions, providing tools for secure exploration of clinical and genomic records to group patients by biomarker, disease, or therapy match, aiding in identifying those who may benefit from precision interventions. The platform includes built-in tools to classify variants using ACMG/AMP standards, prioritize actionable mutations, and surface therapy and trial matches. Automated, configurable reporting generates real-time, dynamic clinical reports, ensuring accurate and up-to-date patient data for authorized personnel. The no-code, user-friendly interface is designed for clinicians, simplifying user interaction. Furthermore, the platform's federated learning approach ensures that sensitive patient data remains secure within its original environment, addressing privacy concerns while still enabling large-scale research and insights.

Lifebit embraces open source, open standards, and an integration-first approach, offering maximum flexibility. Their platform is infrastructure-agnostic and integrates seamlessly with existing systems, including EHRs, national data lakes, databases, and Health Information Exchanges (HIEs). They support data standardization and harmonization using industry best practices like OMOP, FHIR, and GA4GH. The platform also allows for the execution of complex bioinformatics pipelines using frameworks like Nextflow and supports containerized tools and web applications.

Products by Lifebit

1 product in the directory

Lifebit Federated Research & Discovery
Lifebit
Drug Discovery & Research
Lifebit Federated Research & Discovery is a federated data platform with AI-powered harmonization for secure, compliant real-world data analytics, enabling research without moving sensitive data.

Reviews & Opinions

No web reviews on file yet for Lifebit. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Lifebit.

Loading videos...

Videos load interactively. If none appear, search YouTube for Lifebit →

View all on YouTube

Press & Coverage

GenomeWeb
Genomics England, Lifebit to Develop Research Environment for Rare Disease, Cancer
Genomics England announced a partnership with Lifebit to create a trusted research environment for studying cancer and rare diseases, aiming to translate research into healthcare.
2026-07
Genomics England
Genomics England selects Lifebit for enhanced research environment to enable cutting-edge genomic research
Genomics England has chosen Lifebit to develop a next-generation research environment to support advanced genomic research into rare conditions and cancer, with plans to make it available to researchers in 2027.
2026-07
EIN Presswire
Lifebit Launches the World's First Fully Agentic Federated Platform - Redefining Trusted Research Environments
Lifebit introduced Version 4 of its platform, the Lifebit Agentic Federated Platform, which is described as the world's first fully agentic Trusted Research Environment (TRE), designed to make sensitive biomedical and clinical data usable and analyzable through natural language.
2026-01
The National Law Review
Lifebit Launches AI-Automated Airlock to Transform Compliance in Biomedical Results Data Exports
Lifebit announced the release of its AI-Automated Airlock, an AI-powered solution that automates compliant results data exports across global health research environments, aiming to reduce risk and save time.
2025-10
Lifebit
Lifebit Launches AI-Powered Biomedical Data Platform
Lifebit launched its AI-powered Trusted Data Factory (TDF) and Trusted TargetID (TTID) at BioTechX Basel 2025, aiming to transform biomedical data harmonization and target discovery.
2025-10
Lifebit
Lifebit Launches Rapid Data Products for Instant Research
Lifebit introduced Rapid Data Products, a new offering providing biopharma and research organizations with instant access to curated, multimodal real-world datasets through a streamlined procurement and data access experience.
2025-11
EIN Presswire
Lifebit Launches AI-Enhanced Health Data Intelligence Platform to Power Faster, Smarter Discovery
Lifebit announced the launch of its next-generation, end-to-end health data platform, now enhanced with AI capabilities, to redefine how governments, health systems, and industry leaders manage and operationalize biomedical data.
2025-08
Lifebit
Lifebit and Flatiron Health bring cutting-edge research technology to Japan, advancing global cancer care through real-world data
Lifebit and Flatiron Health partnered to bring advanced research technology to Japan, aiming to accelerate cancer research and improve patient treatments through the integration of Lifebit's Trusted Research Environment technology with Flatiron Health's commitment to cancer care.
2024-10

Frequently Asked Questions

Lifebit addresses the challenges of securely accessing and analyzing vast, siloed genomic and biomedical data for precision medicine. Their platform enables healthcare professionals to integrate EHR, genomic, and lab data to accelerate diagnoses, personalize treatments, and advance clinical research, all while maintaining data privacy and compliance.
Lifebit utilizes a federated, security-by-design architecture that allows analysis on distributed datasets without moving the sensitive information, ensuring data remains in its original secure environment. Their platform is compliant with regulations such as HIPAA, GDPR, ISO 27001, SOC 2, FedRAMP, and NIST 800-53, and includes features like AI-Automated Airlock for secure data export governance.
Lifebit offers an AI-enhanced Health Data Ecosystem with modules like the Trusted Research Environment (TRE) for secure analysis, Trusted Data Lakehouse for data management, and Trusted Clinical Environment for clinical actions. Their AI-powered tools facilitate target identification, real-time drug side effect surveillance, and accelerate drug discovery by analyzing multi-omic data and optimizing clinical trials.
Yes, Lifebit's platform is designed for seamless integration with existing systems like EHRs (Epic, Cerner) and national data lakes. It enhances clinical workflows by providing tools for cohort building, variant interpretation, therapy recommendations, and generating traceable clinical reports directly within the Trusted Clinical Environment.
Lifebit is a pioneer in federated learning, which allows AI models to be trained on data from multiple institutions without the data ever leaving its source. This approach protects patient privacy, breaks down data silos, and enables large-scale, collaborative research on diverse datasets for precision medicine and drug development.
Lifebit has established partnerships with prominent organizations such as the NIH, Genomics England, 23andMe, Flatiron Health, CanPath, and Boehringer Ingelheim. These collaborations demonstrate their credibility and integration into major health data ecosystems, and their substantial Series B funding round led by Tiger Global indicates strong investor confidence and financial stability.
Lifebit's Federated Platform is crucial for population genomics, enabling secure data harmonization and federated analysis across national biobanks, health systems, and research centers without moving sensitive data. They provide secure access to diverse RWD from millions of patients, facilitating compliant research and accelerating insights for biomarker discovery and therapeutic target validation.

Investors

Who's funded Lifebit.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.